|
Volumn 1374, Issue 1, 2016, Pages 10-16
|
Working with the U.S. Food and Drug Administration to obtain approval of products under the Animal Rule
|
Author keywords
Animal Rule; efficacy; Food and Drug Administration; safety
|
Indexed keywords
ANTHRAX VACCINE;
BOTULINUM ANTISERUM;
CIPROFLOXACIN;
FILGRASTIM;
HYDROXOCOBALAMIN;
LEVOFLOXACIN;
MOXIFLOXACIN;
OBILTOXAXIMAB;
PEGFILGRASTIM;
PYRIDOSTIGMINE;
RAXIBACUMAB;
ANTHRAX;
ARTICLE;
BONE MARROW SUPPRESSION;
BOTULISM;
COST EFFECTIVENESS ANALYSIS;
CYANIDE POISONING;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG SAFETY;
FOOD AND DRUG ADMINISTRATION;
GAS POISONING;
HUMAN;
LICENSING;
MEDICAL INFORMATION;
NONHUMAN;
PLAGUE;
PNEUMONIC PLAGUE;
SEPTICEMIC PLAGUE;
UNITED STATES;
|
EID: 84983490026
PISSN: 00778923
EISSN: 17496632
Source Type: Book Series
DOI: 10.1111/nyas.13126 Document Type: Article |
Times cited : (15)
|
References (7)
|